Skip to content

Medical-device intelligence

MOB: Test System, Antineutrophil Cytoplasmic Antibodies (Anca)

FDA product code MOB: Test System, Antineutrophil Cytoplasmic Antibodies (Anca). View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
MOB
FDA device name
Test System, Antineutrophil Cytoplasmic Antibodies (Anca)
Device class
2
Regulation number
866.5660
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

75 clearance records and 1 recall records in the covered releases, across 28 source company names and 1 product codes. Dated history runs from Mar 6, 1995 to Aug 21, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202610
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
MOB · Test System, Antineutrophil Cytoplasmic Antibodies (Anca)751

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

76 matching records
Device / recordCompany in FDA recordSourceSource date
VARELISA PR3 ANCA, MODEL NUMBER 17748/17796K041043 · MOBPharmacia Deutschland GmbH510(k)Jul 2, 2004FDA decision date
VARELISA MPO ANCA, MODEL 17648/17696K041040 · MOBSweden Diagnostics (Germany) GmbH510(k)Jun 16, 2004FDA decision date
ZEUS SCIENTIFIC, INC., ATHENA MULTI-LYTE MPO/PR3 IGG TEST SYSTEMK040111 · MOBZeus Scientific, Inc.510(k)Apr 5, 2004FDA decision date
MESACUP TEST PR-3K040711 · MOBRhigene, Inc.510(k)Apr 2, 2004FDA decision date
MESACUP TEST MPO, MODEL 11053K040586 · MOBRhigene, Inc.510(k)Mar 22, 2004FDA decision date
RELISA PR3-ANCA TEST SYSTEM FOR ANTIBODIES TO PROTEINASE 3, MODEL # 7096-16K013283 · MOBImmuno Concepts, Inc.510(k)Nov 14, 2001FDA decision date
RELISA MPO-ANCA TEST SYSTEM FOR ANTIBODIES TO MYELOPEROXIDASE, MODEL # 7096-15K013285 · MOBImmuno Concepts, Inc.510(k)Nov 14, 2001FDA decision date
SCIMEDX PHASE II PR3 IGG ANTIBODY EIAK010287 · MOBScimedx Corp.510(k)Mar 16, 2001FDA decision date
SCIMEDX PHASE II MPO IGG ANTIBODY EIAK010289 · MOBScimedx Corp.510(k)Mar 7, 2001FDA decision date
AUTOSTAT II ANTI-MYELOPEROXIDASE (MPO) ELISAK002215 · MOBCogent Diagnotics , Ltd.510(k)Sep 28, 2000FDA decision date
ANCA COMBI DIAGNOSTIC KIT WITH IF-AIM TECHNOLOGYK001127 · MOBThe Binding Site, Ltd.510(k)Aug 30, 2000FDA decision date
AUTOSTAT II ANTI-PR 3 (C-ANCA)ELISA, HY*TEC ANTI-PR 3 (C-ANCA)ELISAK990796 · MOBCogent Diagnotics , Ltd.510(k)Apr 28, 1999FDA decision date
THE APTUS (AUTOMATED) APPLICATION OF THE MPO ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THE DETK984516 · MOBZeus Scientific, Inc.510(k)Jan 11, 1999FDA decision date
THE APTUS (AUTOMATED) APPLICATION OF THE PR-3 ELISA TEST SYSTEM. AN ANEYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THE DEK984315 · MOBZeus Scientific, Inc.510(k)Dec 17, 1998FDA decision date
IMMUGLO ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) TEST SYTEMK982898 · MOBImmco Diagnostics, Inc.510(k)Nov 30, 1998FDA decision date
THE APTUS (AUTOMATED) APPLICATION OF THE ANCA SCREEN ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FORK984034 · MOBZeus Scientific, Inc.510(k)Nov 30, 1998FDA decision date
IS-ANTI-MPO IGG ELISA TEST SYSTEMK983390 · MOBColumbia Bioscience, Inc.510(k)Nov 18, 1998FDA decision date
IS-ANTI-PR3 IGG ELISA TEST SYSTEMK983740 · MOBColumbia Bioscience, Inc.510(k)Nov 18, 1998FDA decision date
WIELISA ANCA SCREENING KIT TEST SYSTEMK981748 · MOBWieslab AB510(k)Jul 22, 1998FDA decision date
WIELISA ANTI-GBM, ANCA SCREENING KIT TEST SYSTEMK981750 · MOBWieslab AB510(k)Jul 22, 1998FDA decision date
BINDAZYME ANTI-PR3 ENZYME IMMUNOASSAY KITK981029 · MOBThe Binding Site, Ltd.510(k)Jul 20, 1998FDA decision date
BINDAZYME ANTI-MPO ENZYME IMMUNOASSAY KITK981030 · MOBThe Binding Site, Ltd.510(k)Jul 20, 1998FDA decision date
QUANTA LITE PR3 IGG (SERINE PROTEASE) TEST KITK981328 · MOBInova Diagnostics, Inc.510(k)Jun 19, 1998FDA decision date
QUANTA LITE MPO IGG (MYELOPEROXIDASE) TEST KITK981330 · MOBInova Diagnostics, Inc.510(k)Jun 19, 1998FDA decision date
WIELISA MPO ANCA TEST SYSTEMK974166 · MOBWieslab AB510(k)Feb 17, 1998FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗